SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-14-108092
Filing Date
2014-03-20
Accepted
2014-03-20 16:19:56
Documents
12
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 10-K d650569d10k.htm 10-K 1088394
2 EX-10.38 d650569dex1038.htm EX-10.38 96009
3 EX-23.1 d650569dex231.htm EX-23.1 5931
4 EX-31.1 d650569dex311.htm EX-31.1 6969
5 EX-31.2 d650569dex312.htm EX-31.2 6960
6 EX-32.1 d650569dex321.htm EX-32.1 4128
  Complete submission text file 0001193125-14-108092.txt   6869040

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT oxgn-20131231.xml EX-101.INS 907852
8 XBRL TAXONOMY EXTENSION SCHEMA oxgn-20131231.xsd EX-101.SCH 61079
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE oxgn-20131231_cal.xml EX-101.CAL 61577
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE oxgn-20131231_def.xml EX-101.DEF 177000
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE oxgn-20131231_lab.xml EX-101.LAB 469550
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE oxgn-20131231_pre.xml EX-101.PRE 318882
Mailing Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 650-635-7000
OXIGENE INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21990 | Film No.: 14706978
SIC: 2836 Biological Products, (No Diagnostic Substances)